Skip to main content
SSO 2026 Annual Meeting Main banner

Anthony Lucci, Jr., MD

Professor
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center Morgan Welch Inflammatory Breast Cancer Clinic and Research Program
Houston, Texas, United States

Dr. Lucci is the Marvin M. Romsdahl MD PhD endowed Professor of Surgery with dual appointments in the Departments of Breast Surgical Oncology and Surgical Oncology at The University of Texas MD Anderson Cancer Center. Dr. Lucci is the Deputy Director of the MD Anderson Inflammatory Breast Clinic and Research Program, a multidisciplinary clinic that sees over 175 inflammatory breast cancer patients each year.

Dr. Lucci’s clinical focus is on treating patients with breast cancer and melanoma, but he also maintains a laboratory and clinical research team looking at circulating tumor cells and circulating tumor DNA in the blood of cancer patients. He has published 270 peer-reviewed research articles, including a first report in Lancet Oncology of the significance of circulating tumor cells (CTCs) in non-metastatic breast cancer patients. He has contributed to and co-authored several pooled analyses in JNCI and Clinical Cancer Research demonstrating the significance of CTCs in early breast cancer. Dr. Lucci has also published multiple papers on the significance of CTCs in patients with melanoma, including a report in Clinical Cancer Research demonstrating association of CTCs with early relapse in patients with Stage III melanoma.

Dr Lucci has been an active member of the SSO since 2000. He previously has served on the SSO Training Committee (2008-2014), and is a previous recipient of the SSO Clinical Investigator Award for his work with circulating tumor cells. He (or one of his Fellows) has presented at the SSO Annual Meeting almost every year since he became a member.

Presentation(s):